News from the healthcare data industry
Absci’s generative AI platform will use M2GEN’s industry-leading clinicogenomic database with the aim of creating better cancer treatments faster Vancouver, Wash. and TAMPA, Fla – (April 04, 2023) – Absci...
Physicians at Baptist Health Miami Cancer Institute now have access to RWE (real-world evidence), thanks to a relationship with COTA — a leading provider of oncology real-world data and analytics....
BELLEVUE and SEATTLE, Wash., March 22, 2023 (GLOBE NEWSWIRE) — Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B...
Partnership introduces unique patient recruitment and engagement platform to Canada TORONTO, March 09, 2023 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on...
Combining Longitudinal Real-World Data and Clinical Genomics Data Will Enable a More Precise Approach to Cancer Care and Research March 08, 2023 08:05 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–COTA,...
CAMBRIDGE, Mass., Feb. 27, 2023 /PRNewswire/ — Omi Medical Center, part of the Seikoukai Social Medical Corporation and one of Japan’s leading institutions in the use of advanced medical technologies, announced it is partnering with TriNetX...
Collaboration will leverage global patient registries to deliver real-world evidence across rare neuromuscular diseases to biopharmaceutical companies NEW YORK and NEWCASTLE, England, Feb. 22, 2023 /PRNewswire/ — TREAT-NMD Services Ltd, the business arm of...
February 16, 2023 06:29 AM Eastern Standard Time TAMPA, Fla. & TYSONS, Va.–(BUSINESS WIRE)–M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, and Zephyr AI, Inc. (“Zephyr...
Aetion and FDA will use the Aetion Evidence Platform® to study crucial oncology research questions to advance the mission of the Oncology Center of Excellence’s Scientific Collaborative NEW YORK, Jan. 24, 2023 /PRNewswire/...
The Combination of Comprehensive Genomic Profiling with Reference-standard Clinical Data Establishes an Unmatched Translational and Clinical Development Research Platform IRVING, Texas and CAMBRIDGE, Mass., Jan. 9, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular...